Position in LXRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$263,613
+$223,064 QoQ
Shares Held
109,839
+265.7% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 148 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 6%
Shared 0%
None 94%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. LXRX ranks #220 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in LXRX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $263,613 | 109,839 | Shares | Defined | 2026-08-12 | |
| 2025-09-30 | $40,549 | 30,037 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $23,449 | 24,684 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $40,570 | 88,199 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $64,836 | 87,617 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $140,828 | 89,700 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $151,915 | 90,426 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $216,326 | 90,136 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $4,656,235 | 3,043,291 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $3,068,386 | 2,815,034 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,712,375 | 2,931,169 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $8,033,557 | 3,305,991 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $6,258,682 | 3,276,798 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,743,437 | 3,226,433 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,106,964 | 1,132,777 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,360,279 | 1,129,321 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $4,523,473 | 1,148,090 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $5,568,550 | 1,157,703 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $6,027,407 | 1,313,161 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,312,109 | 393,886 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,525,698 | 446,111 | Shares | Defined | 2021-02-19 | |
| 2020-09-30 | $88,838 | 61,694 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $40,382 | 20,191 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $39,167 | 20,086 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||